Literature DB >> 12833583

Comparative study of renal replacement therapy in Korean diabetic end-stage renal disease patients: a single center study.

So Rae Choi1, Sang Cheol Lee, Beom Seok Kim, Soo Young Yoon, Hyeong Cheon Park, Shin Wook Kang, Kyu Hun Choi, Yu Seun Kim, Seung Kyu Ha, Ki Il Park, Dae Suk Han, Ho Yung Lee.   

Abstract

The number of diabetic ESRD patients has increased and death rates of diabetic patients on hemodialysis (HD), peritoneal dialysis (PD) and renal transplantation (RT) have remained higher than the death rate of non-diabetic patients. An attempt was made to compare the clinical characteristics, patients' cumulative survival, and technical survival among the three groups retrospectively according to the mode of renal replacement therapy(RRT), and to analyze the risk factors associated with mortality. A total of 229 diabetic ESRD patients diagnosed between 1986 and 1995 at the Severance Hospital who began dialysis or who underwent a kidney transplant were included and their medical charts were reviewed. Hypertension was the most common co-morbid disease in all study groups. The prevalence of cardiovascular disease was the only co-morbid condition that was significantly different among the three groups, which was highest in the PD group (24.4%) and lowest in the RT group (8%). In the analysis of a patient's cumulative survival rate not adjusted for age and sex, the RT group had the highest survival rate, and the cumulative survival rate of the HD and PD group were similar. The 5-year survival rate of the patients treated with HD, PD and RT was 28.8%, 19.8%, and 72.0%, respectively. No differences were observed in the patient's cumulative survival rate between the HD and PD patients even when it was adjusted for age. When adjusted for age, sex and risk factors, the relative death rate of the RT group was significantly lower in male patients younger than 60 years of age. With the exception of male patients younger than 60 years of age, the PD group showed a slightly lower relative death rate although it was not significant. The multiple Cox regression analysis of patient survival showed that age, serum albumin, BUN, mean hospital days, the presence of cardiovascular disease at the initiation of RRT were associated with mortality. The analysis of the technique survival rate revealed a better result in the HD group compared to PD group, but a limitation in being able to investigate the AVF function disturbed the accuracy of the analysis of technical survival rate. In conclusion, the survival rate between the PD and HD patients was not different and the RT group had the best survival rate. Therefore, kidney transplantation in diabetic ESRD patients should be considered positively if no other contraindicated condition for RT exit.

Entities:  

Mesh:

Year:  2003        PMID: 12833583     DOI: 10.3349/ymj.2003.44.3.454

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  4 in total

1.  Relationship between dialysis modality and mortality.

Authors:  Stephen P McDonald; Mark R Marshall; David W Johnson; Kevan R Polkinghorne
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

2.  Comparison of anthropometric data between end-stage renal disease patients undergoing hemodialysis and healthy adults in Korea.

Authors:  Seoung Woo Lee; Geun Ho Park; Sun Young Lee; Joon Ho Song; Moon-Jae Kim
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

Review 3.  Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis.

Authors:  Cheng Han Ng; Zhi Hao Ong; Hersharan Kaur Sran; Teo Boon Wee
Journal:  Int Urol Nephrol       Date:  2020-10-28       Impact factor: 2.370

4.  Glycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes: Results From a Nationwide Prospective Cohort in Korea.

Authors:  Mi Jung Lee; Young Eun Kwon; Kyoung Sook Park; Youn Kyung Kee; Chang-Yun Yoon; In Mee Han; Seung Gyu Han; Hyung Jung Oh; Jung Tak Park; Seung Hyeok Han; Tae-Hyun Yoo; Yong-Lim Kim; Yon Su Kim; Chul Woo Yang; Nam-Ho Kim; Shin-Wook Kang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.